Gamithromycin 15% Injection

Verify with FDA CVM →

61 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
61
Total Reports
10
Deaths Reported
1640.0%
Death Rate

Active Ingredients

Gamithromycin 15% Injection

Administration Routes

UnknownSubcutaneousTopicalIntramuscularOral

Species Affected

Unknown 26
Cattle 25
Human 10

Most Affected Breeds

Unknown 36
Cattle (unknown) 10
Holstein-Friesian also known as Holstein 6
Aberdeen Angus 4
Cattle (other) 2
Crossbred Bovine/Cattle 2
Shorthorn (unspecified) 1

Most Reported Reactions

Containers, Damaged 16
Uncoded sign 15
Lack of efficacy (bacteria) - NOS 10
Death 8
Accidental exposure 8
Injection site swelling 6
DEATH-TREATMENT FAILURE 4
Lack of efficacy - NOS 4
Injection site reaction NOS 3
Containers, Abnormal 3
Injection site pain 3
Containers, Leaking 3

Outcome Breakdown

Outcome Unknown
20 (51.3%)
Died
10 (25.6%)
Recovered/Normal
8 (20.5%)
Ongoing
1 (2.6%)

Data Summary

Metric Value
Total adverse event reports 61
Reports involving death 10
Case-fatality rate (reported events) 1640.0%
Distinct species in reports 3
Distinct breeds in reports 7
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Gamithromycin 15% Injection Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 61 adverse event reports referencing Gamithromycin 15% Injection, including 10 reports in which the animal died — a 1640.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Gamithromycin 15% Injection. Reported administration routes include Unknown, Subcutaneous, Topical, Intramuscular. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Gamithromycin 15% Injection reports are Unknown (26 reports), Cattle (25 reports), Human (10 reports), with Unknown accounting for the largest share. Within those species, Unknown (36), Cattle (unknown) (10), Holstein-Friesian also known as Holstein (6) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Gamithromycin 15% Injection are Containers, Damaged (16), Uncoded sign (15), Lack of efficacy (bacteria) - NOS (10), Death (8). Of the 39 reports with a coded outcome, Outcome Unknown is the leading category at 51.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Gamithromycin 15% Injection.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial